: Avidity’s stock rockets on Bristol Myers deal that could mean $2.2 billion in milestone payments

Avidity’s stock soared 30.5% early Tuesday on news of an expanded collaboration with Bristol Myers.

Previous post : Canada Goose acquires first European manufacturing plant in Romania, stock pops premarket
Next post Europe Markets: EasyJet and Rolls-Royce shares gain altitude as post-pandemic recoveries take flight